medigraphic.com
ISSN 0188-2198 (Print)

2007, Number 4

Next >>

Rev Mex Cardiol 2007; 18 (4)

Cardiovascular and metabolic impact of fiber addition to a hypercaloric diet in overweighted patients

González-Casas JA, Miranda-Díaz AG, Troyo-Sanromán R, Pascoe-González S, Cardona-Müller D, Cardona-Muñoz EG

Language: Spanish
References: 17
Page: 155-162
PDF size: 156.04 Kb.


ABSTRACT

Introduction: Obesity is a problem of world health. Objective: Evaluate the impact of hypocaloric diet alone or additioned with synthetic or natural fiber over functional and metabolic parameters in obese patients. Methods: We formed 3 groups of patients: group 1, hypocaloric diet alone (17); group 2, diet with lactulose (18); and group 3, diet with psyllium plantago (18). We evaluated: weight, blood pressure, glucose, insulin and cholesterol. Results: The diet produced a reduction of weight in the three groups with respect of basal values, (group 1, -10.48%, group 2, -12.43%, group 3, -13.44%). There was a significant reduction of blood pressure (group 1 -2.99%, group 2, -3.92% (p ‹ 0.016) and group 3, -3.99% (p ‹ 0.011). In all groups there was a decrease in glycaemia, (group 1, -22.74%, group 2, -11.95% y group 3, -28.8%), the insulin, (group 1, -24.68%, group 2, -29.61% y group 3, -52.24%) and total cholesterol (group 1, -15.14%, group 2, -14.89% and group 3, -18.97%). Conclusion: The hypocaloric diet alone or additioned with fiber reduced significantly the weight. The addition of psyllium plantago bettered more the profile of lipids, the sensibility to the insulin and the blood pressure.


REFERENCES

  1. The World Health Report 1998, Life in the 21st Century. Report of the Director-General, World Health Organization, Geneva, 1998: 130-133.

  2. World Health Organization. Obesity; preventing and managing the global epidemic, Geneve: WHO, 1998.

  3. Everson SA, Goldberg DE, Helmrich SP, Lakka TA, Lynch JW, Kaplan GA, Salonen JT. Weight gain and the risk of developing insulin resistance syndrome. Diabetes Care 1998; 21: 1637-1643.

  4. Manicardi V, Camellini L, Belludi G, Coscelli C, Ferrannini E. Evidence for an association of high blood pressure and hyperinsulinaemia in obese man. J Clin Endocrinol Metab 1986; 62: 1302-4.

  5. Golditz GA, Willet WC, Rotnitzky A, Manson JE. Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Inter Med 1995; 122: 481-6.

  6. Després JP. Dyslipidaemia and obesity. Bailliere´s. Clin Endocrinol Metab 1994; 8(3): 629-660.

  7. Bray GA. Complications of obesity. Ann Inter Med 1985; 103: 1052-1062.

  8. Fontbonné A, Charles MA, Thibult N, Richards JL, Claude JR, Warnet JM, et al. Hyperinsulinaemia as a predictor of coronary heart disease mortality in a healthy population. The Paris Prospective Study, 15-year follow-up. Diabetologia 1991; 34: 356-361.

  9. Felson DT. Weight and osteoarthitis. Am J Clin Nutr 1996; 63: 430S-432S.

  10. Grunstein RR, Wilcox I. Sleep-disordered breathing and obesity. Bailliere´s. Clin Endocrinol Metab 1994; 8(3): 601-628.

  11. Everhart JE. Contributions of obesity and weight loss to gallstone disease. Ann Intern Med 1993; 119: 1029-1035.

  12. Hagen J, Deitel M, Khanna RK. Gastroesophageal reflux in the massively obese. Int Surg 1987; 72: 1-3.

  13. Golditz GA. Economic costs of obesity. Am J Clin Nutr 1992; 55: 503S-507S.

  14. Farriol M, Nogues R, Benarroch G. Etiopatogenia de la obesidad: actualidad y futuro. Nutrición Hospitalaria 2001; XVI(4): 113-114.

  15. Secretaría de Salud. Encuesta Nacional de Salud: resultados nacionales. México, D.F.: Secretaría de Salud, 1988.

  16. Resano-Pérez E, I Méndez-Ramírez E, Shamah-Levy T, Rivera JA, Sepúlveda-Amor J. Encuesta Nacional de Nutrición (ENSA II)1999, Salud Pública de México 2003: 45(Suplemento 4).

  17. Olaiz-Fernández G, Rivera-Dommarco J, Shamah-Levy T; Rojas R, Villalpando-Hernández S, Hernández-Ávila M, Sepúlveda-Amor J. Encuesta Nacional de Salud y Nutri




2020     |     www.medigraphic.com